LEGN
Legend Biotech Corp
NASDAQ: LEGN · HEALTHCARE · BIOTECHNOLOGY
$22.77
-3.35% today
Updated 2026-04-29
Market cap
$4.21B
P/E ratio
—
P/S ratio
4.09x
EPS (TTM)
$-1.62
Dividend yield
—
52W range
$16 – $45
Volume
1.9M
Legend Biotech Corp (LEGN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.59M | $49.13M | $61.80M | $75.00M | $68.83M | $117.00M | $285.14M | $627.24M | $1.03B |
| Revenue growth (YoY) | — | +108.2% | +25.8% | +21.4% | -8.2% | +70.0% | +143.7% | +120.0% | +64.5% |
| Cost of revenue | $-96000.00 | — | — | $232.16M | $313.35M | $65.36M | $144.21M | $234.58M | $409.18M |
| Gross profit | $23.69M | $49.13M | $61.80M | $75.00M | $68.83M | $51.64M | $140.93M | $392.66M | $622.44M |
| Gross margin | 100.4% | 100.0% | 100.0% | 100.0% | 100.0% | 44.1% | 49.4% | 62.6% | 60.3% |
| R&D | $8.20M | $60.64M | $161.94M | $232.16M | $313.35M | $335.65M | $382.22M | $413.54M | $415.80M |
| SG&A | $1.62M | $2.77M | $6.75M | $23.13M | $46.96M | $80.63M | $106.77M | $136.78M | $341.60M |
| Operating income | $13.78M | $-1.53M | $-132.51M | $-313.35M | $-392.29M | $-455.62M | $-439.49M | $-303.24M | $-136.86M |
| Operating margin | 58.4% | -3.1% | -214.4% | -417.8% | -570.0% | -389.4% | -154.1% | -48.3% | -13.3% |
| EBITDA | $14.06M | $149000.00 | $-129.35M | $-298.16M | $-392.38M | $-416.54M | $-477.87M | $-113.16M | $-107.78M |
| EBITDA margin | 59.6% | 0.3% | -209.3% | -397.5% | -570.1% | -356.0% | -167.6% | -18.0% | -10.4% |
| EBIT | $13.84M | $-1.53M | $-132.51M | $-308.09M | $-406.30M | $-434.93M | $-498.32M | $-136.52M | $-136.86M |
| Interest expense | $0.00 | $82000.00 | $223000.00 | $4.21M | $900000.00 | $10.80M | $21.79M | $21.61M | $21.46M |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $9.37M | $-2.78M | $-101.59M | $-266.37M | $-403.58M | $-446.35M | $-518.25M | $-177.03M | $-297.58M |
| Net income growth (YoY) | — | -129.7% | -3549.1% | -162.2% | -51.5% | -10.6% | -16.1% | +65.8% | -68.1% |
| Profit margin | 39.7% | -5.7% | -164.4% | -355.2% | -586.4% | -381.5% | -181.8% | -28.2% | -28.8% |